VACCINATIONS: All vaccinations delivered by suitably trained pharmacists have always been covered by indemnity insurance as part of the standard PDA membership apart from Covid-19. For new membership renewals after January 1st, 2026, Covid-19 vaccinations are now also automatically covered.

Home  »   Latest News   »   Reports to prevent Future Deaths with implications for pharmacists

Reports to prevent Future Deaths with implications for pharmacists

The PDA published a news item several months ago highlighting a Coroner’s Section28 report about the sad death of a patient who had died from an overdose of tramadol. The coroner, in that case, highlighted a failure to adequately monitor repeat prescriptions and the PDA felt that there were also potentially questions to answer for the pharmacy or pharmacies which had continued to dispense significant quantities of tramadol to a frail and vulnerable patient.

Mon 30th November 2020 The PDA

In the first new case, the failure related to the shortcomings of patient record handling within primary care. The patient had moved practices, registering with a new practice on 28 November 2019. The patient’s medical records did not arrive at the new practice until late January, shortly before her death on 2 February 2020.

This delay resulted in a practice pharmacist prescribing oxycodone to the patient without access to the patient’s notes which would have shown that oxycodone was used in a previous suicide attempt.

Whilst individual GPs or pharmacists working in general practice have no influence over the transfer of patient records, the PDA feel it is worth advising members to exercise caution when prescribing for patients in the absence of their previous records, particularly where the request is for high-risk medication such as opiates.

The second case involved the admission of a patient to hospital following an accidental overdose of morphine sulphate liquid. Following discharge, the coroner’s court heard from a witness that this admission and discharge would have resulted in a note being added to the ‘Active Problems’ section of the patient’s record to advise of a recent overdose. However, the discharge did not result in morphine liquid being removed from the patient’s repeat list and when the patient requested a repeat it was issued since the request was within the permitted timescale. In this situation, there would be no further checks and the patient record would not be accessed before the prescription was signed. The patient received a 500ml bottle of morphine liquid on 31 October and was found dead on 5 November having ingested a fatal amount of morphine.

For practice pharmacists it is worth revisiting their practice processes:

  • What practice processes are in place when dealing with repeat prescriptions for opiates?
  • What processes are in place to review recently discharged patients following admission for an overdose of a prescribed drug and what actions are taken to mitigate the risk of repeated overdose?

Practices might also want to consider introducing policies which require new patients to provide details of their previous practice and consent to contact the practice to confirm the medication requested if their clinical notes have not yet arrived.

You can read the Prevention of Future Deaths reports here:

First case

thumbnail of Oxycodone-2020-0181

 

Second case

thumbnail of Morphine liquid -2020-0170-2

Related links

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)